Export

Dasatinib
Essential medicine status
General description
Dasatinib is a BCR-ABL tyrosine kinase inhibitor used in treatment protocols for various leukaemias.
INN
Dasatinib
Medicine type
Chemical agent
EML status history
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
  • Oral > Solid: 20 mg tablet; 50 mg tablet; 70 mg tablet; 80 mg tablet; 100 mg tablet; 140 mg tablet